Quarterly Results

CORE HEALTHCARE LTD.

NSE : NABSE : 500091ISIN CODE : INE494A01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE6.870 (0 %)
PREV CLOSE ( ) 6.87
OPEN PRICE ( ) 6.67
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )6.67 7.30
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2007
Sep 2007
Jun 2007
Mar 2007
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
0.00
0.00
0.00
0.00
Total Expenditure
0.18
0.35
0.84
19.21
PBIDT (Excl OI)
-0.18
-0.35
-0.84
-19.21
Other Income
0.00
0.00
0.00
281.57
Operating Profit
-0.18
-0.35
-0.84
262.36
Interest
0.00
0.00
0.00
0.12
Exceptional Items
NA
NA
NA
NA
PBDT
-0.18
-0.35
-0.84
262.24
Depreciation
2.31
2.31
2.31
-219.35
Profit Before Tax
-2.49
-2.66
-3.15
481.58
Tax
0.00
0.00
0.00
0.09
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
-2.49
-2.66
-3.15
481.5
Extraordinary Items
0.00
0.36
0.00
11926.03
Prior Period Expenses
0.00
0.00
-0.06
-163.83
Other Adjustments
NA
NA
NA
NA
Net Profit
-2.49
-2.3
-3.21
12243.69
Equity Capital
339.88
339.88
339.88
339.88
Face Value (IN RS)
10
10
10
10
Reserves
0
0
0
0
Calculated EPS
-0.07
-0.07
-0.09
14.16
Calculated EPS (Annualised)
-0.29
-0.31
-0.37
56.66
No of Public Share Holdings
35793676
35793676
35793676
35793676
% of Public Share Holdings
100
100
100
100
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
NA
NA
NA
NA
PBIDTM%
NA
NA
NA
NA
PBDTM%
NA
NA
NA
NA
PBTM%
NA
NA
NA
NA
PATM%
NA
NA
NA
NA
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.